Please login to the form below

Not currently logged in
Email:
Password:

GW Pharmaceuticals

This page shows the latest GW Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

The year of the blockbuster

The year of the blockbuster

Emanating from the pipelines of global pharma giants like Novartis, Johnson &Johnson and Pfizer, as well companies such as Denmark’s Novo Nordisk and Indivior and GW Pharmaceuticals, both of the ... Epidiolex from GW Pharmaceuticals:With a PDUFA date

Latest news

  • Cancer pain: opioids set to dominate Cancer pain: opioids set to dominate

    Phase III: opioid agonists. GW Pharmaceuticals has developed a buccal spray known as nabiximols or Sativex, which comprises delta-9-tetrahydrocannabinol (27mg/mL) and cannabidiol (25mg/mL), as an analgesic agent ... WEX Pharmaceuticals is conducting a

  • Almirall launches Sativex in Italy Almirall launches Sativex in Italy

    The drug, developed by GW Pharmaceuticals, was approved by Italian authorities in May and comes to the market with a reimbursed priced that GW said was “ consistent with the reimbursed … price ... Sativex has been given a rolling launch in Europe,

  • GW Pharma says German Sativex pricing GW Pharma says German Sativex pricing "unacceptable"

    GW Pharma says German Sativex pricing "unacceptable". May pull MS drug from market. ... GW Pharmaceuticals and partner Almirall have said they may pull Sativex from the market in Germany after failing to agree a price for the drug with the national

  • Almirall files cannabis-based MS drug Sativex in additional EU markets

    by GW Pharmaceuticals. ... It is manufactured by GW Pharma under Home Office licence at an undisclosed location in the UK, and represents the first new therapeutic class to treat spasticity in over 10 years.

  • Novartis gains licence for GW's Sativex

    Novartis gains licence for GW's Sativex. GW Pharmaceuticals has entered into an exclusive licence agreement for Novartis to commercialise Sativex in several key territories. ... GW Pharmaceuticals has entered into an exclusive licence agreement for

More from news
Approximately 0 fully matching, plus 43 partially matching documents found.

Latest appointments

  • GW Pharmaceuticals strengthens research and development team GW Pharmaceuticals strengthens research and development team

    GW Pharmaceuticals strengthens research and development team. Appoints Dr Volker Knappertz and Professor Ben Whalley. ... GW Pharmaceuticals has appointed Dr Volker Knappertz (pictured right) as its chief medical officer (CMO), a role that will see him

  • GW Pharmaceuticals promotes Adam George to MD GW Pharmaceuticals promotes Adam George to MD

    GW Pharmaceuticals promotes Adam George to MD. And Scott Giacobello joins as chief financial officer. ... UK biopharma company GW Pharmaceuticals has promoted chief financial officer Adam George to UK managing director.

  • GW hires Pfizer’s Kenneth Sommerville GW hires Pfizer’s Kenneth Sommerville

    GW hires Pfizer’ s Kenneth Sommerville. Appointed VP clinical research at company specialising in cannabinoids. ... Dr Kenneth Sommerville has left his role at pharma giant Pfizer to join GW Pharma.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics